These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 745692)

  • 1. Prediction of phenelzine outome in depressives.
    Paykel ES; Parker RR; Penrose RJ; Rassaby E
    Neuropharmacology; 1978 Dec; 17(12):1055-6. PubMed ID: 745692
    [No Abstract]   [Full Text] [Related]  

  • 2. Depressive classification and prediction of response to phenelzine.
    Paykel ES; Parker RR; Penrose RJ; Rassaby ER
    Br J Psychiatry; 1979 Jun; 134():572-81. PubMed ID: 476367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
    Robinson DS; Nies A; Ravaris CL; Lamborn KR
    Arch Gen Psychiatry; 1973 Sep; 29(3):407-13. PubMed ID: 4579506
    [No Abstract]   [Full Text] [Related]  

  • 4. Depression subtypes and response to phenelzine, diazepam, and a placebo. Results of a nine hospital collaborative study.
    Raskin A; Schulterbrandt JG; Reatig N; Crook TH; Odle D
    Arch Gen Psychiatry; 1974 Jan; 30(1):66-75. PubMed ID: 4587069
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Wager SG; Nunes E; Rabkin JG; Tricamo E; Markowitz J; Klein DF
    Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine.
    Kosten TR; Frank JB; Dan E; McDougle CJ; Giller EL
    J Nerv Ment Dis; 1991 Jun; 179(6):366-70. PubMed ID: 2051152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylator status and response to phenelzine in depressed patients.
    Johnstone EC; Marsh W
    Lancet; 1973 Mar; 1(7803):567-70. PubMed ID: 4120641
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind trial of phenelzine and amitriptyline in depressed out-patients. A possible differential effect of the drugs on symptoms.
    Kay DW; Garside RF; Fahy TJ
    Br J Psychiatry; 1973 Jul; 123(572):63-7. PubMed ID: 4580991
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation of a monoamine oxidase inhibitor by tryptophan.
    Glassman AH; Platman SR
    J Psychiatr Res; 1969 Dec; 7(2):83-8. PubMed ID: 4917709
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacology of phenelzine.
    Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
    Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Tricamo E; Wager SG; Ocepek-Welikson K; Nunes E; Rabkin JG; Klein DF
    Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic depression: response to placebo, imipramine, and phenelzine.
    Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
    J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of refractory cases of depressive illnesses and their response to combined antidepressant treatment.
    Sethna ER
    Br J Psychiatry; 1974 Mar; 124(0):265-72. PubMed ID: 4599813
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of psychotic and nonpsychotic depression to phenelzine.
    Janicak PG; Pandey GN; Davis JM; Boshes R; Bresnahan D; Sharma R
    Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NIMH collaborative depression studies--a progress report.
    Raskin A
    Psychopharmacol Bull; 1972 Jul; 8(3):55-9. PubMed ID: 4559524
    [No Abstract]   [Full Text] [Related]  

  • 19. A guide for drug use in depressive disorders.
    Raskin A
    Am J Psychiatry; 1974 Feb; 131(2):181-5. PubMed ID: 4358190
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of atypical depression with cognitive therapy or phenelzine.
    Levitan RD
    Arch Gen Psychiatry; 2000 Nov; 57(11):1084; author reply 1084-5. PubMed ID: 11074875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.